Common Stock Compensation

3 Months Ended

Sep. 30, 2018

Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]

Common Stock Compensation

(11) Common Stock Compensation

Stock Option Activity Summary

The Company’s stock option activity for the three months ended September 30, 2018, is as follows:

	Shares (in thousands)			Weighted Average Exercise Price
Outstanding at June 30, 2018		361		$	5.48
Granted		—			—
Exercised		(3	)		2.25
Canceled or expired		(23	)		4.00
Outstanding at September 30, 2018		335		$	5.61

The aggregate intrinsic value of options exercisable at September 30, 2018, was $9 thousand as the fair value of the Company’s common stock is more than the exercise prices of these options. The remaining share-based compensation expense of $283 thousand related to stock options will be recognized over a weighted-average period of 1.61 years.

The table below details the Company’s stock options outstanding as of September 30, 2018:

Range of exercise prices	Number Outstanding		Options Outstanding Weighted- Average Remaining Contractual Life (years)		Weighted- Average Exercise Price		Number Exercisable		Options Exercisable Weighted- Average Exercise Price
$1.60 – 3.55		78,900		3.40	$	3.21		78,900	$	3.21
$5.30 – 5.85		126,306		8.61		5.47		42,616		5.47
$6.00 – 8.35		130,000		6.15		7.19		86,000		6.59
$1.60 – 8.35		335,206		6.43	$	5.61		207,516	$	5.07

Compensation costs recognized related to stock option awards were $41 thousand and $67 thousand for the three months ended September 30, 2018, and 2017, respectively.

Restricted Stock

The Company’s restricted stock activity for the three months ended September 30, 2018, is as follows:

	Shares (in thousands)			Weighted Average Grant-Date Fair Value
Outstanding at June 30, 2018		28		$	10.16
Granted		—			—
Vested		(4	)		8.86
Canceled or expired		(4	)		9.58
Outstanding at September 30, 2018		20		$	10.53

Stock compensation expenses related to restricted stock were $(5) thousand and $55 thousand for the three months ended September 30, 2018, and 2017, respectively. The remaining share-based compensation expense of $31 thousand related to restricted stock awards granted will be recognized over a weighted-average period of 0.90 years.